WASHINGTON (Reuters) - U.S. factory activity slowed for a second straight month in April, with manufacturers complaining about rising commodity prices in the wake of the Trump administration’s tariffs on steel

LONDON (Reuters) - Signs of fading growth momentum across Europe have come as bad news to equity investors hoping for a repeat of 2017’s bumper returns, but many say they’re not

(Reuters) - U.S. stocks fell on Tuesday, driven by Pfizer’s discouraging results, tumbling oil prices and growing fears that tariffs and inflation could weigh on corporate profits.

NEW YORK (Reuters) - The dollar broke into positive territory for the year and U.S. bond yields inched higher again on Tuesday as the recent rise in oil prices fueled expectations

NEW YORK (Reuters) - Pfizer Inc (PFE.N) on Tuesday reported lower-than-expected first-quarter revenue as demand for some key drugs and international sales fell short of estimates, sparking a 5.1 percent drop

Most read articles